{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:55:17Z","timestamp":1788173717317,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T00:00:00Z","timestamp":1617408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T00:00:00Z","timestamp":1617408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s12094-021-02597-7","type":"journal-article","created":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T05:02:46Z","timestamp":1617426166000},"page":"1874-1884","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Association of TYRP1 with hypoxia and its correlation with patient outcome in uveal melanoma"],"prefix":"10.1007","volume":"23","author":[{"given":"J.","family":"Jha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Pushker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Lomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Meel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Chosdol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bakhshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8746-9017","authenticated-orcid":false,"given":"S.","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,3]]},"reference":[{"key":"2597_CR1","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s41588-019-0440-9","volume":"51","author":"AH Shain","year":"2019","unstructured":"Shain AH, Bagger MM, Yu R, et al. The genetic evolution of metastatic uveal melanoma. Nat Genet. 2019;51:1123\u201330.","journal-title":"Nat Genet"},{"key":"2597_CR2","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s00417-019-04413-z","volume":"257","author":"A Hager","year":"2019","unstructured":"Hager A, Meissner F, Riechardt AI, et al. Breakdown of the blood-eye barrier in choroidal melanoma after proton beam radiotherapy. Graefes Arch Clin Exp Ophthalmol. 2019;257:2323\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2597_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1684\/ecn.2020.0449","volume":"31","author":"AM Vuletic","year":"2020","unstructured":"Vuletic AM, Konjevic GM, Larsen AK, et al. Interleukin-4-induced natural killer cell antitumor activity in metastatic melanoma patients. Eur Cytokine Netw. 2020;31:104\u201312.","journal-title":"Eur Cytokine Netw"},{"key":"2597_CR4","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1001\/archopht.1990.01070110090031","volume":"108","author":"JM Seddon","year":"1990","unstructured":"Seddon JM, Gragoudas ES, Glynn RJ, et al. Host factors, UV radiation, and risk of uveal melanoma: a case-control study. Arch Ophthalmol. 1990;108:1274\u201380.","journal-title":"Arch Ophthalmol"},{"key":"2597_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1365-2133.2004.05708.x","volume":"150","author":"MB Lens","year":"2004","unstructured":"Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol. 2004;150:179\u201385.","journal-title":"Br J Dermatol"},{"key":"2597_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/bjo.88.1.39","volume":"88","author":"JW Harbour","year":"2004","unstructured":"Harbour JW, Brantley MA Jr, Hollingsworth H, Gordon M. Association between choroidal pigmentation and posterior uveal melanoma in a white population. Br J Ophthalmol. 2004;88:39\u201343.","journal-title":"Br J Ophthalmol"},{"key":"2597_CR7","doi-asserted-by":"publisher","first-page":"17844","DOI":"10.18632\/oncotarget.7528","volume":"7","author":"AA Brozyna","year":"2016","unstructured":"Brozyna AA, Jozwicki W, Roszkowski K, et al. Melanin content in melanoma metastases affects the outcome of radiotherapy. Oncotarget. 2016;7:17844\u201353.","journal-title":"Oncotarget"},{"key":"2597_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/exd.12618","volume":"24","author":"RM Slominski","year":"2015","unstructured":"Slominski RM, Zmijewski MA, Slominski AT. The role of melanin pigment in melanoma. Exp Dermatol. 2015;24:258\u20139.","journal-title":"Exp Dermatol"},{"key":"2597_CR9","first-page":"293","volume":"5","author":"A Bolander","year":"2008","unstructured":"Bolander A, Agnarsdottir M, Stromberg S, et al. The protein expression of TRP-1 and Galectin-1 in cutaneous malignant melanomas. Cancer Genomics Proteomics. 2008;5:293\u2013300.","journal-title":"Cancer Genomics Proteomics"},{"key":"2597_CR10","first-page":"2066","volume":"13","author":"F Lu","year":"2007","unstructured":"Lu F, Yan D, Zhou X, et al. Expression of melanin-related genes in cultured adult human retinal pigment epithelium and uveal melanoma cells. Mol Vis. 2007;13:2066\u201372.","journal-title":"Mol Vis"},{"key":"2597_CR11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1600-0749.1997.tb00486.x","volume":"10","author":"K Jimbow","year":"1997","unstructured":"Jimbow K, Gomez PF, Toyofuku K, et al. Biological role of tyrosinase related protein and its biosynthesis and transport from TGN to stage I melanosome, late endosome, through gene transfection study. Pigment Cell Res. 1997;10:206\u201313.","journal-title":"Pigment Cell Res"},{"key":"2597_CR12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1080\/14789450.2020.1845654","volume":"17","author":"V Jurisic","year":"2020","unstructured":"Jurisic V. Multiomic analysis of cytokines in immune-oncology. Expert Rev Proteomics. 2020;17:663\u201374.","journal-title":"Expert Rev Proteomics"},{"key":"2597_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10585-006-9024-z","volume":"23","author":"N Victor","year":"2006","unstructured":"Victor N, Ivy A, Jiang BH, et al. Involvement of HIF-1 in invasion of Mum2B uveal melanoma cells. Clin Exp Metas. 2006;23:87\u201396.","journal-title":"Clin Exp Metas"},{"key":"2597_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.abb.2014.06.030","volume":"563","author":"A Slominski","year":"2014","unstructured":"Slominski A, Kim TK, Brozyna AA, et al. The role of melanogenesis in regulation of melanoma behaviour: melanogenesis leads to stimulation of HIF-1\u03b1 expression and HIF-dependent attendant pathways. Arch Biochem Biophys. 2014;563:79\u201393.","journal-title":"Arch Biochem Biophys"},{"key":"2597_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/1476-4598-9-191","volume":"9","author":"L Flamant","year":"2010","unstructured":"Flamant L, Notte A, Ninane N, et al. Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia. Mol Cancer. 2010;9:191.","journal-title":"Mol Cancer"},{"key":"2597_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10792-013-9821-8","volume":"34","author":"S Kashyap","year":"2014","unstructured":"Kashyap S, Venkatesh P, Sen S, et al. Clinicopathologic characteristics of choroidal melanoma in a North `Indian population: analysis of 10-year data. Int Ophthalmol. 2014;34:235\u20139.","journal-title":"Int Ophthalmol"},{"key":"2597_CR17","doi-asserted-by":"crossref","unstructured":"Simpson ER, Gallie BL, Saakyan S, et al. International validation of the American Joint Committee on Cancer\u2019s 7th edition classification of uveal melanoma. JAMA Ophthalmol. 2015;133:376\u201383.","DOI":"10.1001\/jamaophthalmol.2014.5395"},{"key":"2597_CR18","doi-asserted-by":"publisher","unstructured":"Kashyap S, Singh MK, Jha J et al. Prognostic impact of HERC2 protein and pink-eyed dilution protein in uveal melanoma. Hum Cell. 2020;\u00a0https:\/\/doi.org\/10.1007\/s13577-020-00397-9.","DOI":"10.1007\/s13577-020-00397-9"},{"key":"2597_CR19","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/bjc.1998.646","volume":"78","author":"TJ De Vries","year":"1998","unstructured":"De Vries TJ, Trancikova D, Ruiter DJ, et al. High expression of immunotherapay candidate proteins gp 100, MART-1, tyrosinase and TRP-1 in uveal melanoma. Br J Cancer. 1998;78:1156\u201361.","journal-title":"Br J Cancer"},{"key":"2597_CR20","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/modpathol.2011.63","volume":"24","author":"AN Giatromanolaki","year":"2011","unstructured":"Giatromanolaki AN, St Charitoudis G, Bechrakis NE, et al. Autophagy patterns and prognosis in uveal melanomas. Mod Pathol. 2011;24:1036\u201345.","journal-title":"Mod Pathol"},{"key":"2597_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0161-6420(98)92205-9","volume":"105","author":"AD Singh","year":"1998","unstructured":"Singh AD, De Potter P, Fijal BA, et al. Lifetime prevalence of uveal melanoma in white patients with Oculo(dermal) melanocytosis. Ophthalmology. 1998;105:195\u20138.","journal-title":"Ophthalmology"},{"key":"2597_CR22","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.3892\/ol.2016.4280","volume":"11","author":"C Qiu","year":"2016","unstructured":"Qiu C, Li P, Bi J, et al. Differential expression of TYRP1 in adult human retinal pigment epithelium and uveal melanoma cells. Oncol Lett. 2016;11:2379\u201383.","journal-title":"Oncol Lett"},{"key":"2597_CR23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1684\/ecn.2019.0440","volume":"30","author":"KM Martinovic","year":"2019","unstructured":"Martinovic KM, Milicevic M, Larsen AK, et al. Effect of cytokines on NK cell activity and activating receptor expression in high-risk cutaneous melanoma patients. Eur Cytokine Netw. 2019;30:160\u20137.","journal-title":"Eur Cytokine Netw"},{"key":"2597_CR24","doi-asserted-by":"crossref","unstructured":"Shields CL, Kaliki S, Furuta M, et al. American joint committee on cancer classification of uveal melanoma (anatomic stage) predicts prognosis in 7731 patients: The 2013 Zimmerman Lecture. 2015;122:1180\u20131186.","DOI":"10.1016\/j.ophtha.2015.01.026"},{"key":"2597_CR25","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1167\/iovs.03-0538","volume":"44","author":"E Kujala","year":"2003","unstructured":"Kujala E, Makitie T, Kivela T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44:4651\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2597_CR26","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/cancers11071004","volume":"11","author":"NJ Brouwer","year":"2019","unstructured":"Brouwer NJ, Wierenga APA, Gezgin G, et al. Ischemia is related to tumour genetics in uveal melanoma. Cancers (Basel). 2019;11:1004.","journal-title":"Cancers (Basel)"},{"key":"2597_CR27","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1136\/bjophthalmol-2014-305047","volume":"98","author":"TH van Essen","year":"2014","unstructured":"van Essen TH, van Pelt SI, Versluis M, et al. Prognostic parameters in uveal melanoma and their association with BAP1 expression. Br J Ophthalmol. 2014;98:1738\u201343.","journal-title":"Br J Ophthalmol"},{"key":"2597_CR28","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1167\/iovs.13-13345","volume":"55","author":"F Mouriaux","year":"2014","unstructured":"Mouriaux F, Sanschagrin F, Diorio C, et al. Increased HIF-1\u03b1 expression correlates with cell proliferation and vascular markers CD31 and VEGF-A in uveal melanoma. Invest Ophthalmol Vis Sci. 2014;55:1277\u201383.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2597_CR29","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.2217\/fon.11.99","volume":"7","author":"CH Richards","year":"2011","unstructured":"Richards CH, Mohammed Z, Qayyum T, et al. The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review. Future Oncol. 2011;7:1223\u201335.","journal-title":"Future Oncol"},{"key":"2597_CR30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/labinvest.2009.20","volume":"89","author":"S Zhang","year":"2009","unstructured":"Zhang S, Li M, Zhang D, et al. Hypoxia influences linearly patterned programmed cell necrosis and tumor blood supply patterns formation in melanoma. Lab Invest. 2009;89:575\u201386.","journal-title":"Lab Invest"},{"key":"2597_CR31","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1158\/1078-0432.CCR-15-2294","volume":"22","author":"LD Rothermel","year":"2016","unstructured":"Rothermel LD, Sabesan AC, Stephens DJ, et al. Identification of an immunogenic subset of metastatic uveal melanoma. Clin Cancer Res. 2016;22:2237\u201349.","journal-title":"Clin Cancer Res"},{"key":"2597_CR32","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/ncb3623","volume":"19","author":"D Gilot","year":"2017","unstructured":"Gilot D, Migault M, Bachelot L, et al. A non-coding function of TYRP1 mRNA promotes melanoma growth. Nat Cell Biol. 2017;19:1348\u201357.","journal-title":"Nat Cell Biol"},{"key":"2597_CR33","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/j.1365-2230.2009.03706.x","volume":"34","author":"J Valencak","year":"2009","unstructured":"Valencak J, Kittler H, Schmid K, et al. Prognostic relevance of hypoxia inducible factor-1alpha expression in patients with melanoma. Clin Exp Dermatol. 2009;34:962\u20134.","journal-title":"Clin Exp Dermatol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-021-02597-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-021-02597-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-021-02597-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T16:20:46Z","timestamp":1698855646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-021-02597-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,3]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["2597"],"URL":"https:\/\/doi.org\/10.1007\/s12094-021-02597-7","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,3]]},"assertion":[{"value":"9 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approved by Institutional Ethics Committee (IEC), All India Institute of Medical Sciences (AIIMS), New Delhi.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The participants have consented to publish their data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}